GlassScriptPhysician profile
Jorge L Castriz
NPI 1811951601
$6,240.39
in general payments reported to CMS, 2019-2025
21 companies · $2,458 in 2025
The $2,458 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $263 · 2021: $120 · 2022: $2,245 · 2023: $367 · 2024: $541 · 2025: $2,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,765 · Food and Beverage: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,764.70 |
| Food and Beverage | $1,599.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,531.75 | 2020-2025 | Amplatzer Amulet, Accent, Perclose Prostyle |
| Medtronic, INC. | $2,170.02 | 2025 | Micra |
| Novartis Pharmaceuticals Corporation | $306.37 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $267.89 | 2019-2025 | Camzyos |
| Medtronic Vascular, INC. | $230.60 | 2019-2020 | |
| Abiomed | $150.29 | 2024-2025 | Impella |
| Impulse Dynamics (USA) INC. | $97.61 | 2023 | Optimizer |
| W. L. Gore & Associates, INC. | $91.76 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Amgen INC. | $70.83 | 2019-2023 | Repatha |
| Pfizer INC. | $60.76 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $59.81 | 2021-2024 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $38.93 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.58 | 2022-2023 | Lifevest |
| Glaxosmithkline, LLC. | $25.55 | 2020 | |
| Alnylam Pharmaceuticals INC. | $18.05 | 2023 | Amvuttra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $15.84 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.31 | 2021 | |
| Boston Scientific Corporation | $13.31 | 2023 | |
| Philips North America LLC | $12.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Castriz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.